openPR Logo
Press release

Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA) over potential Wrongdoing

02-11-2021 07:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Innate Pharma S.A. (NASDAQ: IPHA) shares.

An investigation on behalf of current long term investors in Innate Pharma S.A. (NASDAQ: IPHA) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Innate Pharma S.A.

Investors who are current long term investors in Innate Pharma S.A. (NASDAQ: IPHA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: IPHA stocks follows a lawsuit filed against Innate Pharma S.A. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: IPHA stocks, concerns whether certain Innate Pharma directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Innate Pharma S.A. touted the results of their various Phase 2 trials as being within expectations, that Innate Pharma S.A. continued to reassure investors that they were eligible for the $100 million payment upon first dosing of Phase 3 trials, that Innate Pharma S.A. failed to timely disclose their renegotiations with AstraZeneca to split the $100 million payment into two $50 million payments, to be partially contingent on performance during the Phase 3 trials, and that as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA) over potential Wrongdoing here

News-ID: 2241056 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Innate

09-01-2025 | Health & Medicine
Getnews
Innate Midwifery Launches Patient Referral Discount Program in Salt Lake Valley
SALT LAKE CITY, UT - Sep 1, 2025 - Innate Midwifery, a licensed maternity care provider based in Salt Lake City, has formally introduced a referral-based discount program intended to broaden access to midwifery services throughout the Salt Lake Valley. The program, now in effect, offers financial incentives to both referring clients and their referrals. Image: https://www.globalnewslines.com/uploads/2025/08/3217874800f5d4dcf26bd3cd3362da7c.jpg Under the structure of the new program, current or previous patients who refer someone to
Sound Therapy Market Is Booming So Rapidly By 2032 | Innate Sounds, Sound Oasis, …
The Sound Therapy Market Research Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Sound Therapy Market Growth from 2025 to 2032, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry players, helping them make informed decisions and stay ahead of the competition in
Oropharyngeal Cancer Market Future Business Opportunities 2025-2032 |Innate Phar …
Latest Report, titled "Oropharyngeal Cancer Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by CoherentMI offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The oropharyngeal cancer market is estimated to be valued at USD 2.11 Bn in 2024 and is expected to reach USD 3.05 Bn by 2031, growing at
Porcine Innate Immunity Market 2021 Clinical Analysis and Precise Outlook-NCBI, …
The “Porcine Innate Immunity Market” report is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis. The innate immune
Lawsuit filed for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA)
An investor, who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), filed a lawsuit over alleged violations of Federal Securities Laws by Innate Pharma S.A.. Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) have certain options and for certain investors are short and strict deadlines running. Deadline: December 22, 2020. NASDAQ: IPHA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. France based Innate Pharma
Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: I …
Innate Pharma S.A. is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by Innate Pharma S.A. regarding its business, its prospects and its operations were materially false and misleading